Filter your results
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
|
|
sorted by
|
|
A cost-effectiveness analysis comparing the originator follitropin alfa to its biosimilars in patients undergoing a medically assisted reproduction program from a French perspectiveJournal of Medical Economics, 2019, 22, pp.108-115. ⟨10.1080/13696998.2018.1551226⟩
Journal articles
hal-03105446v1
|